Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A.M. Vitals: U.S. Appeals Court Hears Stem Cell Arguments
WSJ Online
Tuesday, September 28, 2010 - 10:50am
tags:
stem cells, appeals
Bristol-Myers buy of ZymoGenetics clears hurdle
Marketwatch
Tuesday, September 28, 2010 - 10:47am
tags:
Bristol-Myers Squibb, M&A, ZymoGenetics
Here’s What Medicare Will Ask About Provenge
Pharmalot
Tuesday, September 28, 2010 - 7:47am
tags:
Medicare, Dendreon, Provenge, prostate cancer
King Pharmaceuticals: Looking Ahead to September 2010 Quarterly Results
Seeking Alpha
Tuesday, September 28, 2010 - 7:46am
tags:
earnings, King
Endo Pharma to Buy Qualitest for $1.2B
TheStreet.com
Tuesday, September 28, 2010 - 7:45am
tags:
generics, Endo, Qualitest, M&A
Now That's What I Call a Drug That Works (Seattle Genetics)
Motley Fool
Tuesday, September 28, 2010 - 7:45am
tags:
Seattle Genetics, brentuximab vedotin, Hodgkin's lymphoma
Pfizer Inc. (NYSE:PFE) – Q3 2010 Earnings Preview
iStockAnalyst
Monday, September 27, 2010 - 10:06pm
tags:
Pfizer, earnings
Will Johnson & Johnson Blow It Next Quarter?
Motley Fool
Monday, September 27, 2010 - 10:04pm
tags:
JNJ, earnings
Actelion's Experimental Drug for Brain Hemorrhage Fails to Meet Study Goal
Bloomberg
Monday, September 27, 2010 - 5:46pm
tags:
Actelion, brain hemorrhage, clazosentan
Allergan, Hologic Pass FDA Checkpoints
Forbes
Monday, September 27, 2010 - 5:44pm
tags:
Hologic, FDA, Allergan, Ozurdex
Pfizer halts study of Sutent for prostate cancer
Marketwatch
Monday, September 27, 2010 - 5:42pm
tags:
Sutent, prostate cancer, Pfizer
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Monday, September 27, 2010 - 5:40pm
tags:
Ariad Pharmaceuticals, Corcept Therapeutics, ridaforolimus, Merck, Cushing's disease, Corlux, Novartis
Pfizer Sues Novo Nordisk in London Court Over Patent on Insulin Device
Bloomberg
Monday, September 27, 2010 - 12:24pm
tags:
Pfizer, Novo Nordisk, lawsuits, diabetes
Pfizer plans more partnerships in Asia
Outsourcing Pharma
Monday, September 27, 2010 - 12:23pm
tags:
Pfizer, Asia, partnerships, CROs
Centocor seeks expansion of Simponi use
Bizjournals.com
Monday, September 27, 2010 - 12:19pm
tags:
Janssen Biotech, Simponi, rheumatoid arthritis
Biovail/Valeant Shareholders Approve Valeant Deal
WSJ Online
Monday, September 27, 2010 - 12:16pm
tags:
M&A, Biovail, Valeant Pharmaceuticals
Genomics co. OpGen lands $17.3M in Series B
Fierce Biotech
Monday, September 27, 2010 - 12:14pm
tags:
Series B, financing, genomics, OpGen
Feds Give Lipitor Whistleblower Lawsuit A Boost
Pharmalot
Monday, September 27, 2010 - 12:13pm
tags:
Lipitor, whistleblowers, Pfizer
Good News for Hospira
Yahoo/Zacks.com
Monday, September 27, 2010 - 12:01pm
tags:
Nivestem, Hospira, biosimilars, Amgen
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Monday, September 27, 2010 - 11:59am
tags:
Novartis, MS, multiple sclerosis, Gilenya

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.